Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
about
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1Serum uric acid level and its association with cardiometabolic risk factors in prediabetic subjects.Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus.Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells.Metabolic syndrome is linked to chromosome 7q21 and associated with genetic variants in CD36 and GNAT3 in Mexican AmericansEffects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetesEnvironmentally Relevant Dose of Bisphenol A Does Not Affect Lipid Metabolism and Has No Synergetic or Antagonistic Effects on Genistein's Beneficial Roles on Lipid MetabolismEfficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.Circulating glucagon-like peptide-1 increases in response to short-term overfeeding in men.Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial.Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans.Mechanisms for the cardiovascular effects of glucagon-like peptide-1.Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids.Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes.Diurnal rhythms of plasma GLP-1 levels in normal and overweight/obese subjects: lack of effect of weight loss.Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity.Influence of hemodialysis on incretin hormones and insulin secretion in diabetic and non-diabetic patients.Circulating levels of apelin, glucagon-like peptide and visfatin in hypercholesterolemic-hyperhomocysteinemic guinea-pigs: their relation with NO metabolism.Postmeal increment in intact glucagon-like peptide 1 level, but not intact glucose-dependent insulinotropic polypeptide levels, is inversely associated with metabolic syndrome in patients with type 2 diabetes.Baseline type 2 diabetes had a significant association with elevated high sensitivity cardiac troponin T levels in Chinese community-dwelling population: a 5-year prospective analysis.Plasma levels of glucagon-like peptide 1 and markers of obesity among young and healthy adults.Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients1-1.Basal GLP-1 levels in morbidly obese patients following biliopancreatic diversion surgery.Effect of fermented camel milk on glucose metabolism, insulin resistance, and inflammatory biomarkers of adolescents with metabolic syndrome: A double-blind, randomized, crossover trial.The Effect of Dietary Supplementation of Green Tea Catechins on Cardiovascular Disease Risk Markers in Humans: A Systematic Review of Clinical Trials
P2860
Q26752511-57906D5D-0A86-45C3-B6D3-C261CEBFBEF5Q33771402-A77B3640-458B-4178-9448-18EA4F777805Q34158074-9824D7EB-C4E2-44F1-B790-A696EE01E6DFQ34332004-AF072347-A538-482D-B798-287EE510F547Q34872692-2545B4AE-091B-4C58-A5CC-5A385D1187B6Q35116119-F555E300-5D82-457B-8D4F-68DF047DA1E4Q35184941-349CC6D7-32F0-4EE5-B449-C31BE3331F3BQ36015716-21B4F8E4-D3C6-4EE2-A536-3D7BA0143350Q36284121-8E2A99AA-5437-49C0-8A29-D7A0672B70FFQ36323314-DA9D43C0-E7DB-4445-99CE-0BFA35DF52A4Q36766657-F9263269-BFE2-44EB-B70A-E820DEC63F13Q37121652-E03DE2A5-6A1C-4432-A9F2-7361F473CFB7Q37153223-514C3C07-1F56-45BA-8D24-5B6CA267CE86Q38589032-AA03FF2A-12C4-4C51-9D6F-F267AA4A9846Q40666632-46D8D700-F511-46C7-8C68-DEA044531780Q41145553-36BBBDBA-A6CE-445A-A32A-5096BD37FDEEQ41646131-D35BC411-CBF5-4893-8312-C0DEAF71AEFFQ44396877-A709409C-3099-4334-8A52-07F7B6BC4F09Q44740682-0B3524E4-EE90-4508-884A-C37B696F7BC2Q46379488-E8B2E1C6-1A2C-42D9-BAA2-A8632198BD23Q48190264-CA521B46-DA83-4049-96CE-CD64ECA8B87FQ49675698-8732DF91-8891-4F08-9A1A-170F0395D0E1Q51304866-5EB0C0E3-8805-4AED-A518-01118C1D1B74Q51318715-6EDF9878-5348-4333-9D1F-0FB7C0865CE5Q51353310-44CF90EE-D46C-4102-B332-7675EC6F001EQ55190984-5DA3999B-89B7-420E-A359-E3F24BFB5962Q59159538-F1DD270D-C2A6-400A-8703-F0BF0020D29D
P2860
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Elevated circulating levels of ...... ts with cardiovascular disease
@ast
Elevated circulating levels of ...... ts with cardiovascular disease
@en
type
label
Elevated circulating levels of ...... ts with cardiovascular disease
@ast
Elevated circulating levels of ...... ts with cardiovascular disease
@en
prefLabel
Elevated circulating levels of ...... ts with cardiovascular disease
@ast
Elevated circulating levels of ...... ts with cardiovascular disease
@en
P2093
P2860
P356
P1476
Elevated circulating levels of ...... ts with cardiovascular disease
@en
P2093
Atsuhiko Matsunaga
Minako Yamaoka-Tojo
Naonobu Takahira
Naoyoshi Aoyama
Taiki Tojo
Takashi Masuda
Tohru Izumi
P2860
P2888
P356
10.1186/1475-2840-9-17
P407
P577
2010-05-14T00:00:00Z
P5875
P6179
1015405290